Patents Assigned to SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
  • PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG OLAMINE
    Publication number: 20210308104
    Abstract: The present invention relates to a pharmaceutical capsule composition comprising eltrombopag olamine or a pharmaceutically acceptable salt thereof for use in the treatment of thrombocytopenia. Furthermore, the present invention relates to an improved, simple, rapid, cost-effective, time-saving and industrially available method of preparing the capsule composition comprising eltrombopag olamine.
    Type: Application
    Filed: July 26, 2019
    Publication date: October 7, 2021
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: ALI TURKYILMAZ, EDIZ YILDIRIM, GULCIN TOK
  • PHARMACEUTICAL COMPOSITIONS OF FLURBIPROFEN AND 5-HT1 - RECEPTOR AGONISTS
    Publication number: 20210161843
    Abstract: Pharmaceutical compositions comprising flurbiprofen or a pharmaceutically acceptable salt thereof in combination with at least one 5-HT1-receptor agonist or a pharmaceutically acceptable salt thereof. In this invention, the composition comprising flurbiprofen and 5-HT1-receptor agonists are used for treating or preventing migraine headache. Furthermore, in this invention, in order to overcome incompatibility and stability problems of these active agents, some solutions were offered, and stable pharmaceutical compositions have been developed.
    Type: Application
    Filed: December 13, 2018
    Publication date: June 3, 2021
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Ali TURKYILMAZ, Melda MISIRLI, Emine TUNCAY, Ediz YILDIRIM
  • Pharmaceutical combinations of dabigatran and proton pump inhibitors
    Patent number: 10130618
    Abstract: This invention is a novel pharmaceutical composition comprising dabigatran or a pharmaceutically acceptable salt thereof in combination with a proton pump inhibitor for use in the antithrombotic treatment with preventing or reducing the risk of a gastrointestinal disorder.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: November 20, 2018
    Assignee: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Ali Türkyilmaz, Mehtap Saydam, Yildiz Gülkok, Nur Kirat Uzunogullari, Sevgi Gökcek
  • Modified release pharmaceutical compositions of dexlansoprazole
    Patent number: 9114085
    Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: August 25, 2015
    Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Ezetimibe compositions
    Patent number: 9095515
    Abstract: This invention is a novel pharmaceutical composition of ezetimibe or a pharmaceutically acceptable salt thereof comprising one or more pharmaceutically acceptable excipients having high bioavailability with improved solubility and dissolution rate which is stable throughout the shelflife, methods for their preparation, and methods for treatment using the same.
    Type: Grant
    Filed: March 15, 2010
    Date of Patent: August 4, 2015
    Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Levent Oner, Ali Turkyilmaz, Ibrahim Murat Uzer, Gaye Ramazanoglu
  • Orally disintegrating tablets of zolmitriptan and process for preparing the same
    Patent number: 8906949
    Abstract: Silicon dioxide free orally disintegrating tablet formulations of zolmitriptan or a pharmaceutically acceptable salt thereof having magnesium carbonate heavy and sodium stearyl fumarate with one or more pharmaceutically acceptable excipients and a process for preparing such a formulation and its use in the treatment of migraines.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: December 9, 2014
    Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Gulay Yelken
  • FLURBIPROFEN AND MUSCLE RELAXANT COMBINATIONS
    Publication number: 20140308348
    Abstract: This invention is a novel pharmaceutical composition comprising flurbiprofen or a pharmaceutically acceptable salt thereof in combination with an ?-2 adrenergic receptor agonist or a gamma-aminobutiric acid receptor agonist with anti-inflammatory, analgesic and myorelaxant activity.
    Type: Application
    Filed: May 20, 2014
    Publication date: October 16, 2014
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp
  • MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF DEXLANSOPRAZOLE
    Publication number: 20140255484
    Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: May 12, 2014
    Publication date: September 11, 2014
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Unit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Flurbiprofen and muscle relaxant combinations
    Patent number: 8778391
    Abstract: This invention is a novel pharmaceutical composition comprising flurbiprofen or a pharmaceutically acceptable salt thereof in combination with an ?-2 adrenergic receptor agonist or a gamma-aminobutiric acid receptor agonist with anti-inflammatory, analgesic and myorelaxant activity.
    Type: Grant
    Filed: May 8, 2008
    Date of Patent: July 15, 2014
    Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp
  • Oral tablet compositions of dexlansoprazole
    Patent number: 8758818
    Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: June 24, 2014
    Assignee: Sanovel Ilac Sanayi ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Dual release oral tablet compositions of dexlansoprazole
    Patent number: 8753682
    Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: June 17, 2014
    Assignee: Sanovel Ilac Sanayi ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Modified release pharmaceutical compositions of dexlansoprazole
    Patent number: 8741345
    Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: June 3, 2014
    Assignee: Sanovel ILAC Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Flurbiprofen and muscle relaxant gel combinations thereof
    Patent number: 8691778
    Abstract: A topical pharmaceutical gel includes flurbiprofen or a pharmaceutically acceptable salt of flurbiprofen, thiocolchicoside or a pharmaceutically acceptable salt of thiocolchicoside, and menthol. Pharmaceutical combinations of flurbiprofen, thiocolchicoside, and menthol in the form of topical gels with anti-inflammatory, analgesic, and myorelaxant activities are described.
    Type: Grant
    Filed: September 20, 2010
    Date of Patent: April 8, 2014
    Assignee: Sanovel Ilac Sanayi ve Ticaret Anonim Sirketi
    Inventors: Fatih Cakir, Ali Turkyilmaz, Umit Cifter
  • DUAL RELEASE ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE
    Publication number: 20140030328
    Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: September 23, 2013
    Publication date: January 30, 2014
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE
    Publication number: 20140023709
    Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: September 23, 2013
    Publication date: January 23, 2014
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Extended release pharmaceutical compositions of levetiracetam
    Patent number: 8512746
    Abstract: Extended release pharmaceutical compositions of levetiracetam or pharmaceutically acceptable salts thereof in the form of a tablet comprising glyceryl behenate and a polymethacrylate polymer with at least one pharmaceutically acceptable excipient.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: August 20, 2013
    Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Hasan Ali Turp, Gulay Yelken, Asiye Sezgia, Ali Turkyilmaz, Levent Oner
  • NEW PHARMACEUTICAL COMBINATIONS
    Publication number: 20110305757
    Abstract: A pharmaceutical composition including a compound of Formula I (Compound I) or pharmaceutically acceptable salts thereof and one or more diuretics as effective components, wherein said one or more diuretics are selected from thiazide derivatives. Methods for preparing the pharmaceutical compound including Compound I and thiazide derivatives and its use for preventing or treating hypertension in mammals, particularly in humans.
    Type: Application
    Filed: June 13, 2011
    Publication date: December 15, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Onur Mutlu, Gaye Ramazanoglu
  • DUAL RELEASE ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE
    Publication number: 20110274753
    Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: May 5, 2011
    Publication date: November 10, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • TRIMETAZIDINE FORMULATION WITH DIFFERENT RELEASE PROFILES
    Publication number: 20110274751
    Abstract: A multilayered solid oral pharmaceutical formulation of trimetazidine or a pharmaceutically acceptable salt or polymorph of trimetazidine wherein one layer of said formulation provides controlled release, while the other layer provides immediate release.
    Type: Application
    Filed: May 3, 2011
    Publication date: November 10, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Nur Pehlivan Akalin, Aylin Yildirim, Levent Oner
  • ORALLY DISINTEGRATING TABLET FORMULATIONS OF MIRTAZAPINE AND PROCESS FOR PREPARING THE SAME
    Publication number: 20110257159
    Abstract: Silicon dioxide free orally disintegrating tablet formulations of mirtazapine or a pharmaceutically acceptable salt thereof having crospovidone and sodium stearyl fumarate and one or more pharmaceutically acceptable excipients and a process for preparing such a formulation.
    Type: Application
    Filed: April 15, 2011
    Publication date: October 20, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp, Gulay Yelken